AstraZeneca Plans To Drug The Undruggable With Scorpion Partnership

Pays $75m Upfront

Microscopic view of cancer cells. Cancer occurs when a cell's gene mutations make the cell unable to correct DNA damage.
The Partners Aim To Disrupt The Activity Of Highly-Validated Cancer Targets • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business